Literature DB >> 11704923

Sporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1.

S Mead1, S P Mahal, J Beck, T Campbell, M Farrall, E Fisher, J Collinge.   

Abstract

Human prion diseases have inherited, sporadic, and acquired etiologies. The appearance of the novel acquired prion disease, variant Creutzfeldt-Jakob disease (vCJD), and the demonstration that it is caused by the same prion strain as that causing bovine spongiform encephalopathy, has led to fears of a major human epidemic. The etiology of classical (sporadic) CJD, which has a worldwide incidence, remains obscure. A common human prion-protein-gene (PRNP) polymorphism (encoding either methionine or valine at codon 129) is a strong susceptibility factor for sporadic and acquired prion disease. However, a quantitative-trait-locus study of prion incubation periods in mice has demonstrated an important factor that is close to Prnp but is independent of its coding sequence or that of the nearby prion-like doppel gene (Prnd). We have analyzed the PRNP locus for such tightly linked susceptibility factors. Fifty-six polymorphic sites have been identified within 25 kb of the PRNP open reading frame, including sites within the PRNP promoter and the PRNP 3' untranslated region. These have been characterized in 61 Centre d'Etude du Polymorphisme Humain (CEPH) families, demonstrating extensive linkage disequilibrium around PRNP and the existence of 11 major European PRNP haplotypes. Haplotype frequencies estimated in healthy U.K. control individuals were very similar to those deduced in the CEPH families. A common haplotype was overrepresented in patients with sporadic CJD (sCJD). Through use of a log-linear modeling approach to simultaneously model Hardy-Weinberg and linkage disequilibria, a significant independent association was found between sCJD and a polymorphism upstream of PRNP exon 1 (P=.005), in addition to the strong susceptibility conferred by codon 129 (P=2x10(-8)). However, although our sample size was necessarily small, no association was found between these polymorphisms and vCJD or iatrogenic CJD, in keeping with their having distinct disease mechanisms. In addition, there was no evidence of a PRNP founder effect in the first reported geographical cluster of vCJD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704923      PMCID: PMC1235534          DOI: 10.1086/324710

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice.

Authors:  S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Testing for association between disease and linked marker loci: a log-linear-model analysis.

Authors:  L Tiret; P Amouyel; R Rakotovao; F Cambien; P Ducimetière
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

3.  Codon 129 changes in the prion protein gene in Caucasians.

Authors:  F Owen; M Poulter; J Collinge; T J Crow
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

4.  Log-linear models for linked loci.

Authors:  B S Weir; S R Wilson
Journal:  Biometrics       Date:  1986-09       Impact factor: 2.571

5.  Aminoacid polymorphism in human prion protein and age at death in inherited prion disease.

Authors:  H E Baker; M Poulter; T J Crow; C D Frith; R Lofthouse; R M Ridley
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

6.  Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000.

Authors:  S Cousens; P G Smith; H Ward; D Everington; R S Knight; M Zeidler; G Stewart; E A Smith-Bathgate; M A Macleod; J Mackenzie; R G Will
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

Review 7.  Variant Creutzfeldt-Jakob disease.

Authors:  J Collinge
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

8.  Molecular genetics of human prion diseases in Germany.

Authors:  O Windl; A Giese; W Schulz-Schaeffer; I Zerr; K Skworc; S Arendt; C Oberdieck; M Bodemer; S Poser; H A Kretzschmar
Journal:  Hum Genet       Date:  1999-09       Impact factor: 4.132

9.  The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature.

Authors:  P Brown; F Cathala; R F Raubertas; D C Gajdusek; P Castaigne
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

10.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.

Authors:  S B Prusiner; M Scott; D Foster; K M Pan; D Groth; C Mirenda; M Torchia; S L Yang; D Serban; G A Carlson
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

View more
  35 in total

1.  Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study.

Authors:  C Vollmert; O Windl; W Xiang; A Rosenberger; I Zerr; H-E Wichmann; H Bickeböller; T Illig; H A Kretzschmar
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

Review 2.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

3.  Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation.

Authors:  Ana B Rodríguez-Martínez; Miguel A Alfonso-Sánchez; José A Peña; Raquel Sánchez-Valle; Inga Zerr; Sabina Capellari; Miguel Calero; Juan J Zarranz; Marian M de Pancorbo
Journal:  Neurogenetics       Date:  2008-03-18       Impact factor: 2.660

4.  Association between the PRNP 1368 polymorphism and the occurrence of sporadic Creutzfeldt-Jakob disease.

Authors:  Jolanta Bratosiewicz-Wąsik; Joanna Smoleń-Dzirba; Annemieke J Rozemuller; Casper Jansen; Wim Spliet; Gerard H Jansen; Tomasz J Wąsik; Paweł P Liberski
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

5.  The prion protein gene in humans revisited: lessons from a worldwide resequencing study.

Authors:  Marta Soldevila; Aida M Andrés; Anna Ramírez-Soriano; Tomàs Marquès-Bonet; Francesc Calafell; Arcadi Navarro; Jaume Bertranpetit
Journal:  Genome Res       Date:  2005-12-20       Impact factor: 9.043

6.  Methods for high-density admixture mapping of disease genes.

Authors:  Nick Patterson; Neil Hattangadi; Barton Lane; Kirk E Lohmueller; David A Hafler; Jorge R Oksenberg; Stephen L Hauser; Michael W Smith; Stephen J O'Brien; David Altshuler; Mark J Daly; David Reich
Journal:  Am J Hum Genet       Date:  2004-04-14       Impact factor: 11.025

7.  The M129V polymorphism of codon 129 in the prion gene (PRNP) in the Danish population.

Authors:  Henrik Dyrbye; Helle Broholm; Morten Hanefeld Dziegiel; Henning Laursen
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

8.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

9.  Two adjacent nuclear factor-binding domains activate expression from the human PRNP promoter.

Authors:  Michael J Taheny; Nerik Izkhakov; Alexander A Vostrov; Wolfgang W Quitschke
Journal:  BMC Res Notes       Date:  2009-09-09

10.  PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism.

Authors:  Matthew T Bishop; Catherine Pennington; Craig A Heath; Robert G Will; Richard S G Knight
Journal:  BMC Med Genet       Date:  2009-12-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.